Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (10): 1090-1093.DOI: 10.3969/j.issn.1673-8640.2021.010.021
Previous Articles Next Articles
Received:
2020-05-11
Online:
2021-10-30
Published:
2021-11-08
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.010.021
[1] |
SHEARER A E, SMITH R J. Genetics:advances in genetic testing for deafness[J]. Curr Opin Pediatr, 2012, 24(6):679-686.
DOI URL |
[2] | AKBARIAZAR E, VAHABI A, ABDI RAD I. Report of a novel splicing mutation in the MYO15A gene in a patient with sensorineural hearing loss and spectrum of the MYO15A mutations[J]. Clin Med Insights Case Rep, 2019, 12:1179547619871907. |
[3] | 任晓菲, 朱姝, 朱宝生, 等. MYO15A基因突变在非综合征型聋中的研究进展[J]. 听力学及言语疾病杂志, 2017, 25(4):436-440. |
[4] | 陈庆双, 项延包, 李焕铮, 等. MYO15A基因突变致聋家系的遗传学分析[J]. 中国优生与遗传杂志, 2018, 26(10):43-45. |
[5] |
MA D, SHEN S, GAO H, et al. A novel nonsense mutation in MYO15A is associated with non-syndromic hearing loss:a case report[J]. BMC Medical Genet, 2018, 19(1):133.
DOI URL |
[6] |
BERG J S, POWELL B C, CHENEY R E. A millennial myosin census[J]. Mol Biol Cell, 2001, 12(4):780-794.
DOI URL |
[7] |
SWEENEY H L, HOUDUSSE A. Structural and functional insights into the myosin motor mechanism[J]. Ann Rev Biophys, 2010, 39:539-557.
DOI URL |
[8] | KRENDEL M, MOOSEKER M S. Myosins:tails(and heads) of functional diversity[J]. Physiology(Bethesda), 2005, 20:239-251. |
[9] |
CHANG M Y, KIM A R, KIM N K, et al. Identification and clinical implications of novel MYO15A mutations in a non-consanguineous Korean family by targeted exome sequencing[J]. Mol Cell, 2015, 38(9):781-788.
DOI URL |
[10] |
WOO H M, PARK H J, BAEK J I, et al. Whole-exome sequencing identifies MYO15A mutations as a cause of autosomal recessive nonsyndromic hearing loss in Korean families[J]. BMC Med Genet, 2013, 14:72.
DOI URL |
[11] | 张静, 关静, 王秋菊. MYO15A与遗传性耳聋[J]. 中华耳科学杂志, 2019, 17(1):98-105. |
[12] |
MEHREGAN H, MOHSENI M, JALALVAND K, et al. Novel mutations in MYTH4-FERM domains of myosin 15 are associated with autosomal recessive nonsyndromic hearing loss[J]. Int J Pediatr Otorhinolaryngol, 2019, 117:115-126.
DOI URL |
[13] |
XIA H, HUANG X, GUO Y, et al. Identification of a novel MYO15A mutation in a Chinese family with autosomal recessive nonsyndromic hearing loss[J]. PLoS One, 2015, 10(8):e0136306.
DOI URL |
[14] |
ANDERSON D W, PROBST F J, BELYANTSEVA I A, et al. The motor and tail regions of myosin XV are critical for normal structure and function of auditory and vestibular hair cells[J]. Hum Mol Genet, 2000, 9(12):1729-1738.
DOI URL |
[15] |
FATTAHI Z, SHEARER A E, BABANEJAD M, et al. Screening for MYO15A gene mutations in autosomal recessive nonsyndromic,GJB2 negative Iranian deaf population[J]. Am J Med Genet A, 2012, 158A(8):1857-1864.
DOI URL |
[16] |
MIYAGAWA M, NISHIO S Y, HATTORI M, et al. Mutations in the MYO15A gene are a significant cause of nonsyndromic hearing loss:massively parallel DNA sequencing-based analysis[J]. Ann Otol Rhinol Laryngol, 2015, 124(Suppl 1):158S-168S.
DOI URL |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||